2/8
07:15 pm
podd
What Analysts Think Is Shifting The Story For Insulet (PODD) And Its Edge Now [Yahoo! Finance]
Low
Report
What Analysts Think Is Shifting The Story For Insulet (PODD) And Its Edge Now [Yahoo! Finance]
2/6
08:22 am
podd
Insulin Pump Market Insights $2.1B Revenue from Insulet, 500,000+ U.S. Users and 47.8% Adoption in Canada Driven by Government Funding [Yahoo! Finance]
Low
Report
Insulin Pump Market Insights $2.1B Revenue from Insulet, 500,000+ U.S. Users and 47.8% Adoption in Canada Driven by Government Funding [Yahoo! Finance]
2/5
07:00 am
podd
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
Medium
Report
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
2/4
08:43 am
podd
Insulet (NASDAQ:PODD) had its price target lowered by analysts at Stifel Nicolaus from $370.00 to $350.00. They now have a "buy" rating on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its price target lowered by analysts at Stifel Nicolaus from $370.00 to $350.00. They now have a "buy" rating on the stock.
2/2
08:07 pm
podd
Insulet Corporation (PODD): A Bull Case Theory [Yahoo! Finance]
Low
Report
Insulet Corporation (PODD): A Bull Case Theory [Yahoo! Finance]
1/30
07:12 pm
podd
Reasons Why Hedge Funds Favor Insulet Corp (PODD) [Yahoo! Finance]
Low
Report
Reasons Why Hedge Funds Favor Insulet Corp (PODD) [Yahoo! Finance]
1/30
07:12 pm
podd
Assessing Insulet (PODD) Valuation After Recent Share Price Weakness And Growth Expectations [Yahoo! Finance]
Low
Report
Assessing Insulet (PODD) Valuation After Recent Share Price Weakness And Growth Expectations [Yahoo! Finance]
1/30
12:43 pm
podd
Is It Time To Reassess Insulet (PODD) After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
Is It Time To Reassess Insulet (PODD) After Recent Share Price Weakness [Yahoo! Finance]
1/29
04:17 am
podd
ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing [Yahoo! Finance]
Low
Report
ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing [Yahoo! Finance]
1/26
05:07 pm
podd
Insulet (NASDAQ:PODD) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
Low
Report
Insulet (NASDAQ:PODD) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
1/24
05:08 am
podd
Insulet (NASDAQ:PODD) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Insulet (NASDAQ:PODD) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/22
11:50 am
podd
What You Need To Know Ahead of Insulet's Earnings Release [Yahoo! Finance]
Low
Report
What You Need To Know Ahead of Insulet's Earnings Release [Yahoo! Finance]
1/15
07:02 pm
podd
JPM26: Insulet presents optimistic growth plan heading into 2026 [Yahoo! Finance]
Low
Report
JPM26: Insulet presents optimistic growth plan heading into 2026 [Yahoo! Finance]
1/14
01:01 pm
podd
Bernstein Reduces Firm's PT on Insulet (PODD) Stock [Yahoo! Finance]
Low
Report
Bernstein Reduces Firm's PT on Insulet (PODD) Stock [Yahoo! Finance]
1/12
09:00 am
podd
Insulet (NASDAQ:PODD) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $274.00 price target on the stock.
Low
Report
Insulet (NASDAQ:PODD) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $274.00 price target on the stock.
1/10
01:24 pm
podd
Why Analysts See The Insulet (PODD) Story Shifting As Omnipod Growth Meets Valuation Questions [Yahoo! Finance]
Medium
Report
Why Analysts See The Insulet (PODD) Story Shifting As Omnipod Growth Meets Valuation Questions [Yahoo! Finance]
1/9
07:03 pm
podd
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 [Yahoo! Finance]
Medium
Report
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 [Yahoo! Finance]
1/9
07:18 am
podd
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
1/9
07:00 am
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
1/9
06:00 am
podd
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
Low
Report
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
1/8
09:41 am
podd
What Provides InsuletCorp. (PODD) With a Durable Competitive Advantage? [Yahoo! Finance]
Low
Report
What Provides InsuletCorp. (PODD) With a Durable Competitive Advantage? [Yahoo! Finance]
1/7
07:12 am
podd
Insulet (NASDAQ:PODD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Insulet (NASDAQ:PODD) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
1/6
07:22 am
podd
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health [Yahoo! Finance]
Low
Report
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health [Yahoo! Finance]
1/6
07:00 am
podd
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
Low
Report
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
1/5
02:52 pm
podd
Declining Stock and Solid Fundamentals: Is The Market Wrong About Insulet Corporation (NASDAQ:PODD)? [Yahoo! Finance]
Low
Report
Declining Stock and Solid Fundamentals: Is The Market Wrong About Insulet Corporation (NASDAQ:PODD)? [Yahoo! Finance]